VYNE Therapeutics Inc. (VYNE) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

VYNE Therapeutics Inc. (VYNE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $11.2M, listed on NASDAQ, employing roughly 13 people, carrying a beta of 2.00 to the broader market. VYNE Therapeutics Inc. Led by David T. Domzalski, public since 2018-01-25.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for VYNE as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →